Economic landscapes of human tissues and cells for clinical application in the EU

While tissues and cells are usually donated by citizens without any payment, they still require further processing before they can be applied as a therapy. This involves costs and different options to recover (part of) these costs. This study was therefore financed under the Health Programme to help increase understanding of these economic factors. Such understanding helps Member States to organize this essential and often public healthcare service at best.